Litcius/Paper detail

Synthesis and Biological Evaluation of Novel 1,2,3-Triazole Based Pyrido[4,3-d]pyrimidines as Potent Anticancer and EGFR Inhibitors

Rakesh Sreerama, Nitin Kumar, Satheesh Kumar Nukala, E. Ramya Sucharitha, H. Ramesh Babu, Sirassu Narsimha

2021Russian Journal of General Chemistry21 citationsDOI

Abstract

Abstract This study is devoted to the efficient and practical synthesis of a novel series of pyrido[4,3-d]pyrimidine derivatives attached to 1,2,3-triazole ring and lipophilic terminal fractions. Structure of the newly synthesized compounds is well characterized by various spectroscopic methods. An in vitro MTT cytotoxicity assay has been used to compare cytotoxic effects of the synthesized compounds on MCF-7, HeLa, and A-549. The kinase inhibitory assay against tyrosine kinase EGFR has been performed for the potent compounds and the results are supporting their in vitro anticancer activity. Further study of their binding affinity has been performed by molecular docking with the EGFR site. The molecular docking and cytotoxic tests results correlate well.

Topics & Concepts

ChemistryHeLaCytotoxicityPyrimidineMTT assayIn vitroTriazoleDocking (animal)StereochemistryCombinatorial chemistryMolecular modelEGFR inhibitors1,2,3-TriazoleTyrosine kinaseCytotoxic T cellBiochemistryEpidermal growth factor receptorOrganic chemistryReceptorMedicineNursingClick Chemistry and ApplicationsSynthesis and biological activitySynthesis and Characterization of Heterocyclic Compounds
Synthesis and Biological Evaluation of Novel 1,2,3-Triazole Based Pyrido[4,3-d]pyrimidines as Potent Anticancer and EGFR Inhibitors | Litcius